Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study for the Detection of Stem/Progenitor Cell Up-regulation Using Aldagen BRIGHT Technology in Peripheral Blood After Hyperbaric Oxygen Therapy (HBOT) Treatment

NCT01740908 is registered in ClinicalTrials.gov with Restorix Research Institute, LLLP as lead sponsor.

NCT NCT01740908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01740908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study for the Detection of Stem/Progenitor Cell Up-regulation Using Aldagen BRIGHT Technology in Peripheral Blood After Hyperbaric Oxygen Therapy (HBOT) Treatment
Lead sponsor
Restorix Research Institute, LLLP
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2012
Completion date
January 31, 2013
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

changes in peripheral blood population numbers and type.